These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 24137579)

  • 21. Are the 18F-FDG positron emission tomography/computed tomography findings in bronchopulmonary carcinoid tumors different than expected?
    Alpay L; Lacin T; Kanbur S; Kiral H; Ersoz E; Bayram S; Dogruyol T; Baysungur V; Yalcinkaya I
    Hell J Nucl Med; 2013; 16(3):213-7. PubMed ID: 24251310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of 18F-FDG PET/CT for initial staging of nasal type natural killer/T-cell lymphoma: a comparison with conventional staging methods.
    Moon SH; Cho SK; Kim WS; Kim SJ; Chan Ahn Y; Choe YS; Lee KH; Kim BT; Choi JY
    J Nucl Med; 2013 Jul; 54(7):1039-44. PubMed ID: 23658217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
    Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG PET and PET/CT in Burkitt's lymphoma.
    Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA
    Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.
    Marcus C; Antoniou A; Rahmim A; Ladenson P; Subramaniam RM
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):281-8. PubMed ID: 25676871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of 18F-FDG PET/CT in the evaluation of pediatric transplant patients.
    Yang J; Zhuang H
    Hell J Nucl Med; 2015; 18(2):136-9. PubMed ID: 26187213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of interim 18F-FDG PET in patients with diffuse large B-Cell lymphoma: SUV-based assessment at 4 cycles of chemotherapy.
    Itti E; Lin C; Dupuis J; Paone G; Capacchione D; Rahmouni A; Haioun C; Meignan M
    J Nucl Med; 2009 Apr; 50(4):527-33. PubMed ID: 19289424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using PET-CT in the restaging of primitive mediastinal B-cell lymphoma (PMBCL) after chemotherapy: which criteria should we use?
    Giunta F; Zotta M; Menga M; Balma M; Bellò M; Passera R; Filippi AR; Chiappella A; Ladetto M; Ricardi U; Vitolo U; Bisi G
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):214-9. PubMed ID: 25669764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study.
    Frings V; van Velden FH; Velasquez LM; Hayes W; van de Ven PM; Hoekstra OS; Boellaard R
    Radiology; 2014 Nov; 273(2):539-48. PubMed ID: 24865311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings.
    Jain TK; Sharma P; Suman SK; Faizi NA; Bal C; Kumar R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(6):394-6. PubMed ID: 23743243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG PET/CT compared to conventional imaging modalities in pediatric primary bone tumors.
    London K; Stege C; Cross S; Onikul E; Graf N; Kaspers G; Dalla-Pozza L; Howman-Giles R
    Pediatr Radiol; 2012 Apr; 42(4):418-30. PubMed ID: 22134535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
    Castellucci P; Nanni C; Farsad M; Alinari L; Zinzani P; Stefoni V; Battista G; Valentini D; Pettinato C; Marengo M; Boschi S; Canini R; Baccarani M; Monetti N; Franchi R; Rampin L; Fanti S; Rubello D
    Nucl Med Commun; 2005 Aug; 26(8):689-94. PubMed ID: 16000986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [18F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis].
    Ramos-Font C; Rebollo Aguirre AC; Villegas Portero R; Romero Tabares A; Gallego Peinado M; Llamas Elvira JM
    Rev Esp Med Nucl; 2009; 28(2):48-55. PubMed ID: 19406048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative analysis of basal and interim PET/CT images for predicting tumor recurrence in patients with Hodgkin's lymphoma.
    Strigari L; Attili A; Duggento A; Chiaravalloti A; Schillaci O; Guerrisi MG
    Nucl Med Commun; 2016 Jan; 37(1):16-22. PubMed ID: 26440569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of 18F-FDG PET/CT in staging and follow-up of lymphoma in pediatric and young adult patients.
    Miller E; Metser U; Avrahami G; Dvir R; Valdman D; Sira LB; Sayar D; Burstein Y; Toren A; Yaniv I; Even-Sapir E
    J Comput Assist Tomogr; 2006; 30(4):689-94. PubMed ID: 16845304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic status-dependent thymic changes on 18F-FDG PET/CT in an adult patient with lymphoma who underwent 2 phases of chemotherapy.
    Fan Q; Su M; Li L; Li F; Tian R
    Clin Nucl Med; 2014 Mar; 39(3):e243-5. PubMed ID: 24300345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice.
    Karantanis D; Kalkanis D; Allen-Auerbach MS; Herrmann K; Pomykala KL; Bogsrud TV; Lowe VJ; Czernin J
    Nuklearmedizin; 2014; 53(2):19-25. PubMed ID: 24473996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated radiation exposure and cancer risk from CT and PET/CT scans in patients with lymphoma.
    Guttikonda R; Herts BR; Dong F; Baker ME; Fenner KB; Pohlman B
    Eur J Radiol; 2014 Jun; 83(6):1011-1015. PubMed ID: 24656401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of FDG-PET scan in the management of pediatric mature B cell non-Hodgkin's lymphoma. CCHE experience.
    Abdel Rahman H; Sedky M; Hamoda A; Raafat T; Youssef A; Omar W; Hassanein O; Moussa E
    J Egypt Natl Canc Inst; 2016 Jun; 28(2):95-9. PubMed ID: 27133974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse functional effects of chemotherapy on whole-brain metabolism: a PET/CT quantitative analysis of FDG metabolic pattern of the "chemo-brain".
    Sorokin J; Saboury B; Ahn JA; Moghbel M; Basu S; Alavi A
    Clin Nucl Med; 2014 Jan; 39(1):e35-9. PubMed ID: 23751834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.